Target type: molecularfunction
Binding to a small interfering RNA, a 21-23 nucleotide RNA that is processed from double stranded RNA (dsRNA) by an RNAse enzyme. [PMID:15066275, PMID:15066283]
siRNA binding is a molecular function that describes the interaction of small interfering RNA (siRNA) molecules with their target molecules. siRNAs are short, double-stranded RNA molecules that play a crucial role in RNA interference (RNAi), a powerful and highly specific mechanism for regulating gene expression at the post-transcriptional level. The primary function of siRNA is to silence gene expression by targeting specific messenger RNA (mRNA) molecules for degradation. siRNA binding involves a series of intricate steps: 1. Recognition: siRNA molecules, with their characteristic double-stranded structure, are recognized by a protein complex known as the RNA-induced silencing complex (RISC). 2. Unwinding: The RISC complex unwinds the siRNA duplex, separating the two strands. One strand, known as the guide strand, remains associated with RISC, while the other strand, called the passenger strand, is typically degraded. 3. Target Recognition: The guide strand, with its specific sequence, guides RISC to its target mRNA molecule. The guide strand base pairs with the complementary sequence on the mRNA, forming a stable hybrid. 4. Cleavage: Once the siRNA is bound to its target mRNA, RISC uses its enzymatic activity (typically provided by the Argonaute protein) to cleave the mRNA molecule. This cleavage disrupts the mRNA, preventing it from being translated into protein. 5. mRNA Degradation: The cleaved mRNA fragments are rapidly degraded by cellular machinery, effectively silencing the gene expression. siRNA binding is a highly specific process, as the guide strand sequence dictates the target mRNA molecule. This specificity makes siRNA a valuable tool for research and therapeutic applications, allowing scientists and clinicians to manipulate gene expression in a targeted manner. siRNA binding has been successfully employed in a wide range of applications, including gene silencing studies, drug discovery, and therapeutic interventions for various diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein argonaute-2 | A protein argonaute-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UKV8] | Homo sapiens (human) |
Protein argonaute-2 | A protein argonaute-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UKV8] | Homo sapiens (human) |
Toll-like receptor 7 | A Toll-like receptor 7 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9NYK1] | Homo sapiens (human) |
Toll-like receptor 9 | A Toll-like receptor 9 that is encoded in the genome of human. [] | Homo sapiens (human) |
RISC-loading complex subunit TARBP2 | A RISC-loading complex subunit TARBP2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15633] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
enoxacin | enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea. Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID. | 1,8-naphthyridine derivative; amino acid; fluoroquinolone antibiotic; monocarboxylic acid; N-arylpiperazine; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor |
hydroxychloroquine | hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions. Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) | aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug |
sulfaguanidine | sulfaguanidine : A sulfonamide incorporating a guanidine moiety used to block the synthesis of folic acid; mostly used in veterinary medicine Sulfaguanidine: A sulfanilamide antimicrobial agent that is used to treat enteric infections. | sulfonamide antibiotic | antiinfective agent |
sulfanilamide | substituted aniline; sulfonamide; sulfonamide antibiotic | antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor | |
sulfisomidine | sulfisomidine : A sulfonamide consisting of pyrimidine having methyl substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. Sulfisomidine: A sulfanilamide antibacterial agent. | pyrimidines; sulfonamide; sulfonamide antibiotic | antiinfective agent |
uridine monophosphate | uridine 5'-monophosphate : A pyrimidine ribonucleoside 5'-monophosphate having uracil as the nucleobase. Uridine Monophosphate: 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. | pyrimidine ribonucleoside 5'-monophosphate; uridine 5'-phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite |
imiquimod | imiquimod : An imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. Imiquimod: A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS. | imidazoquinoline | antineoplastic agent; interferon inducer |
schisanhenol b | schisanhenol B: isolated from kernels of Schisandra rubriflora; structure given in first source | ||
resiquimod | S 28463: structure given in first source | imidazoquinoline | |
N'-[(4-chlorophenyl)-oxomethyl]-2-methyl-4-thiazolecarbohydrazide | carbonyl compound; organohalogen compound | ||
N'2-[3-(trifluoromethyl)benzoyl]-3-aminopyrazine-2-carbohydrazide | (trifluoromethyl)benzenes | ||
sm360320 | SM360320: Proc Natl Acad Sci U S A 2006 Feb 7;103(6):1828-33 | ||
cl 075 | |||
vtx-2337 | |||
dsr-6434 | DSR-6434: structure in first source | ||
gardiquimod | |||
gs-9620 |